She was followed at home by her private physician and was thought to have an acute poststreptococcal glomerulonephritis although hypertension or edema never occurred and no cultural or antibody ...

Caribou Biosciences, Inc.’s CRBU share price has dipped by 8.48%, which has investors questioning if this is right time to ...

Even if a child or adult recovers from encephalitis from a measles infection, Garcia Carreno added, there is a 25% risk of ...

Mozart is regarded as one of the greatest composers of all time, and his compositions played a crucial role in shaping ...

Fintel reports that on March 28, 2025, Leerink Partners downgraded their outlook for Equillium (NasdaqCM:EQ) from Outperform to Market Perform. Analyst Price Forecast Suggests 736.07% Upside As of ...

First, SC291 for B-cell mediated autoimmune conditions like lupus nephritis, extrarenal relapsed ... such as non-Hodgkin lymphoma [NHL], acute lymphoblastic leukemia [ALL], and chronic lymphocytic ...

AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

AstraZeneca's IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

Equities researchers at Leerink Partnrs issued their FY2029 EPS estimates for shares of Equillium in a research report issued to clients and investors on Friday, March 28th. Leerink Partnrs analyst T.

Immune-Mediated Nephritis with Renal Dysfunction UNLOXCYT can cause immune ... Transplant-related complications include hyperacute graft-versus-host disease (GVHD), acute GVHD, chronic GVHD, hepatic ...

Travere Therapeutics, Inc., today announced that the Company will present three abstracts, including one late-breaking oral presentation, at the upcoming National Kidney Foundation (NKF) Spring ...